Average Co-Inventor Count = 4.14
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (23 from 3,923 patents)
2. Other (2 from 832,680 patents)
25 patents:
1. 12433949 - Sustained release delivery systems comprising traceless linkers
2. 11389541 - Sustained delivery of angiopoetin-like 3 polypeptides
3. 10751417 - Sustained release delivery systems comprising traceless linkers
4. 10550102 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
5. 10537563 - Methods for treating ocular disease using inhibitors of CSF-1R
6. 10316020 - Indane derivatives and the use thereof as soluble guanylate cyclase activators
7. 10208018 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
8. 10174006 - Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
9. 10093663 - Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
10. 9957254 - Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
11. 9765067 - Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
12. 9682968 - Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
13. 9676728 - 2-benzyl-benzimidazole complement factor B inhibitors and uses thereof
14. 9505755 - Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
15. 9475806 - Complement factor B inhibitors and uses there of